iHateHospitals.com

MEDICAL NEWS:
Brief Report: Coronary Heart Disease Events Associated with Hormone Therapy in Younger and Older Women

Content Type Journal Article
Category Erratum
DOI 10.1007/s11606-008-0762-2
Authors

Shelley R. Salpeter, Santa Clara Valley Medical Center Department of Medicine San Jose CA USA
Judith M. E. Walsh, University of California, San Francisco Department of Medicine San Francisco CA USA
Elizabeth Greyber, Santa Clara Valley Medical [...]

CANCER NEWS: Well, it has been a couple months since we posted anything here…..you know it really is true…life does go on! Valerie had implants put in last October, and with all the changes her body went through after Chemo and Radiation, they (the implants) have decided not to cooperate. So, Valerie is scheduled [...]

CANCER NEWS: Well, it has been a couple months since we posted anything here…..you know it really is true…life does go on! Valerie had implants put in last October, and with all the changes her body went through after Chemo and Radiation, they (the implants) have decided not to cooperate. So, Valerie is scheduled [...]

CANCER NEWS: IntroductionPatients with primary operable estrogen receptor negative (ER-) breast (women’s) cancer account for approximately 30% of all cases and generally have worse prognosis (outlook) than ER+ patients. Nevertheless, a significant proportion of ER- cases have favourable outcome and could potentially benefit from a less aggressive course of therapy. Identification of such good [...]

CANCER NEWS: Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, announced publication of a Phase 1 clinical study(1) on its BiTE(R) antibody blinatumomab (MT103/MEDI-538) in this week’s issue of Science. The article is available at www.sciencemag.org. Blinatumomab is being co-developed with MedImmune. Blinatumomab is [...]

CANCER NEWS: Stem cell scientists in the region have helped to develop a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and improved survival rates. The UK-led team, headed by scientists from Durham University and the North-East England Stem Cell Institute, (NESCI), studied tissue samples [...]

(Mesothelioma News) ROCKVILLE, Md. — Human Genome Sciences, Inc. today announced that it has completed the enrollment and initial dosing of patients in a randomized Phase 2 trial of HGS-ETR1 (mapatumumab) in combination with the chemotherapy (serious, serious drugs) agents paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC). “There is [...]

DRUGS & RX: Studies demonstrate efficacy and safety of VisonacTM and the potential for a simplified Photodynamic Therapy (PDT) procedure for treatment of moderate to severe acne
Oslo, Norway, August 27, 2008 - Photocure announces positive preliminary results…

View the source of this article…

Photocure Announces Positive Phase II Results with Visonac for Acne was another wonderful and [...]

DRUGS & RX: PARSIPPANY, N.J.–(BUSINESS WIRE)–Aug. 26, 2008 - The Medicines Company (NASDAQ: MDCO) today announced that the results of VELOCITY, a pivotal Phase 3 safety and efficacy trial of its new intravenous (IV) therapy Cleviprex(TM) (clevidipine…

View the source of this article…

New Publication Shows Cleviprex is Safe and Effective for Treatment of Acute, Severe Hypertension [...]

DRUGS & RX: EXTON, Pa., August 25, 2008 /PRNewswire-FirstCall/ — Isolagen(TM), Inc. announced today results from a prospective, open label, Phase II study (IT-R-007) of Isolagen Therapy(TM) for the treatment of facial wrinkles and creases in approximately 40…

View the source of this article…

Isolagen Reports Positive Results from Open Label, Phase II Study of Isolagen Therapy [...]

DRUGS & RX: MELBOURNE, Australia, Aug 21, 2008 - (ABN Newswire) - Australian regenerative medicine company Mesoblast Limited (ASX:MSB)(PINK:MBLTY), today announced that its allogeneic, or “off-the-shelf”, cell therapy…

View the source of this article…

Mesoblast Limited’s (ASX:MSB) Allogeneic, "Off-The-Shelf", Stem Cells Are Safe And Effective For Cervical Spine Fusion was another wonderful and informative drug and pharmaceutical [...]

DRUGS & RX: WOODCLIFF LAKE, N.J., August 23, 2008 /PRNewswire/ — Eisai Corporation of North America and its partner Helsinn Healthcare SA today announced that the U.S. Food and Drug Administration (FDA) has approved a new oral formulation of Aloxi…

View the source of this article…

FDA Approves Aloxi (palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced [...]